# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-21-066564
Filing Date
2021-03-03
Accepted
2021-03-03 07:01:19
Documents
47
Period of Report
2021-03-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d134078d8k.htm iXBRL | 8-K | 24980
2 | EX-99.1 | d134078dex991.htm | EX-99.1 | 34643
6 | GRAPHIC | g134078ex99_1s10g1.jpg | GRAPHIC | 398926
7 | GRAPHIC | g134078ex99_1s11g1.jpg | GRAPHIC | 532620
8 | GRAPHIC | g134078ex99_1s12g1.jpg | GRAPHIC | 607752
9 | GRAPHIC | g134078ex99_1s13g1.jpg | GRAPHIC | 495111
10 | GRAPHIC | g134078ex99_1s14g1.jpg | GRAPHIC | 384117
11 | GRAPHIC | g134078ex99_1s15g1.jpg | GRAPHIC | 630740
12 | GRAPHIC | g134078ex99_1s16g1.jpg | GRAPHIC | 595985
13 | GRAPHIC | g134078ex99_1s17g1.jpg | GRAPHIC | 607133
14 | GRAPHIC | g134078ex99_1s18g1.jpg | GRAPHIC | 509491
15 | GRAPHIC | g134078ex99_1s19g1.jpg | GRAPHIC | 698940
16 | GRAPHIC | g134078ex99_1s1g1.jpg | GRAPHIC | 270292
17 | GRAPHIC | g134078ex99_1s20g1.jpg | GRAPHIC | 401448
18 | GRAPHIC | g134078ex99_1s21g1.jpg | GRAPHIC | 483929
19 | GRAPHIC | g134078ex99_1s22g1.jpg | GRAPHIC | 390065
20 | GRAPHIC | g134078ex99_1s23g1.jpg | GRAPHIC | 739853
21 | GRAPHIC | g134078ex99_1s24g1.jpg | GRAPHIC | 360398
22 | GRAPHIC | g134078ex99_1s25g1.jpg | GRAPHIC | 424434
23 | GRAPHIC | g134078ex99_1s26g1.jpg | GRAPHIC | 636514
24 | GRAPHIC | g134078ex99_1s27g1.jpg | GRAPHIC | 691544
25 | GRAPHIC | g134078ex99_1s28g1.jpg | GRAPHIC | 476967
26 | GRAPHIC | g134078ex99_1s29g1.jpg | GRAPHIC | 563594
27 | GRAPHIC | g134078ex99_1s2g1.jpg | GRAPHIC | 1046367
28 | GRAPHIC | g134078ex99_1s30g1.jpg | GRAPHIC | 442976
29 | GRAPHIC | g134078ex99_1s31g1.jpg | GRAPHIC | 360799
30 | GRAPHIC | g134078ex99_1s32g1.jpg | GRAPHIC | 209489
31 | GRAPHIC | g134078ex99_1s33g1.jpg | GRAPHIC | 716366
32 | GRAPHIC | g134078ex99_1s34g1.jpg | GRAPHIC | 644761
33 | GRAPHIC | g134078ex99_1s3g1.jpg | GRAPHIC | 531721
34 | GRAPHIC | g134078ex99_1s4g1.jpg | GRAPHIC | 631387
35 | GRAPHIC | g134078ex99_1s5g1.jpg | GRAPHIC | 771738
36 | GRAPHIC | g134078ex99_1s6g1.jpg | GRAPHIC | 395719
37 | GRAPHIC | g134078ex99_1s7g1.jpg | GRAPHIC | 494986
38 | GRAPHIC | g134078ex99_1s8g1.jpg | GRAPHIC | 800748
39 | GRAPHIC | g134078ex99_1s9g1.jpg | GRAPHIC | 511862
| Complete submission text file | 0001193125-21-066564.txt |  | 25618327

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | cbio-20210303.xsd | EX-101.SCH | 3101
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cbio-20210303_lab.xml | EX-101.LAB | 18137
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cbio-20210303_pre.xml | EX-101.PRE | 11428
40 | EXTRACTED XBRL INSTANCE DOCUMENT | d134078d8k_htm.xml | XML | 3341

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 21707195
SIC: 2834 Pharmaceutical Preparations